Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...
Үндсэн зохиолчид: | Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Oxford University Press
2019
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
-н: Wang, Y, зэрэг
Хэвлэсэн: (2020) -
Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
-н: Parvaiz A Koul, зэрэг
Хэвлэсэн: (2024-01-01) -
Does Oseltamivir Really Reduce Complications of Influenza?
-н: Del Mar, C, зэрэг
Хэвлэсэн: (2011) -
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
-н: Chairat, K, зэрэг
Хэвлэсэн: (2016) -
Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
-н: Mihai Maria Elena, зэрэг
Хэвлэсэн: (2024-04-01)